One-sample sign tests (OSS) were used to determine whether scores of a given group were significantly different from zero.
The commonly used bone replacement material, Bio-Oss, was used as a control.
The Oslo-3 item Social Support Scale (OSS-3) was used.
An intravenous administration of 30 μg/kg fentanyl citrate (Janssen, Beerse, Belgium) and 0.1 mg/kg rocuronium bromide (Esmeron, Organon, Oss, The Netherlands) was used for endotracheal intubation (8 mm endotracheal tube, Hi-Contour, Mallinckrodt Medical, Athlone, Ireland).
A reconstruction prosthesis (OSS, Biomet, Warsaw, Indiana) was used in all patients, fixed to the bone by a Compress device.
The overall number of those skeletal aging features was used as an OSS.
Bio-Oss® (Geistlich Pharma AG®, Wolhusen, Switzerland) was used as the xenograft in 16 patients.
To explore the underlying structure and proximality of the HSCL-10 and OSS-3 scales, a principal component analysis (PCA) was used.
The mandibular ramus was used for autogenous bone graft and Bio-Oss® (Geistlich, Wolhusen, Switzerland) for heterogeneous bone graft.
This sample was used for a preliminary validation study of OIDP and OSS, for which a sample size of 100 200 is recommended [ 17].
